Very-low-calorie diet: A quick therapeutic tool to improve β cell function in morbidly obese patients with type 2 diabetes

American Journal of Clinical Nutrition

Volumn 95, Issue 3, 2012, Pages 609-613

  Malandrucco, Ilaria ^a,b   Pasqualetti, Patrizio ^b   Giordani, Ilaria ^a,b   Manfellotto, Dario ^b   De Marco, Federica ^a,b   Alegiani, Filippo ^b   Sidoti, Anna Maria ^b   Picconi, Fabiana ^a,b   Di Flaviani, Alessandra ^a,b   Frajese, Gaetano ^a,b   Bonadonna, Riccardo C ^c,d   Frontoni, Simona ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SAN GIOVANNI CALIBITA FATEBENEFRATELLI HOSPITAL   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d Azienda Ospedaliera   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; BODY SURFACE; CALORIC RESTRICTION; CLINICAL ARTICLE; DIABETIC PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; LOW CALORY DIET; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET CELL FUNCTION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; BLOOD GLUCOSE; BODY MASS INDEX; CALORIC RESTRICTION; CHOLESTEROL; CREATININE; DIABETES MELLITUS, TYPE 2; ENERGY INTAKE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; OBESITY, MORBID; TRIGLYCERIDES; WEIGHT LOSS;

EID: 84857868331     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.023697     Document Type: Article

References (31)

1. UKPDS Group. UK Prospective Diabetes Study 7. Response of fasting plasma glucose to diet therapy in newly presenting type 2 patients with diabetes. Metabolism 1990;39:905-12.
2. Henry RR, Scheaffer L, Olefsky JM. Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1985;61:917-25. (Pubitemid 16218491)
3. Taylor R. Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause. Diabetologia 2008;51:1781-9.
4. Wing RR, Blair EH, Bononi P, Marcus MD, Watanabe R, Bergman RN. Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care 1994;17:30-6.
5. Kelley DE, Wing R, Buonocore C, Sturis J, Polonsky K, Fitzsimmons M. Relative effects of calorie restriction and weight loss in non-insulin- dependent diabetes mellitus. J Clin Endocrinol Metab 1993;77: 1287-93. (Pubitemid 23345484)
6. Lara-Castro C, Newcomer BR, Rowell J, Wallace P, Shaughnessy SM, Munoz AJ, Shiflett AM, Rigsby DY, Lawrence JC, Bohning DE, et al. Effects of short-term very low calorie diet on intramyocellular lipid and insulin sensitivity in non-diabetics and type 2 diabetic patients. Metabolism 2008;57:1-8. (Pubitemid 350234968)
7. Markovic TP, Jenkis AB, Campbell LV, Furler SM, Kraegen EW, Chisholm DJ. The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM. Diabetes Care 1998; 21:687-94. (Pubitemid 28487056)
8. Gumbiner B, Polonsky KS, Beltz WF, Griver K, Wallace P, Brechtel G, Henry RR. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1990;70:1594-602.
9. Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 2011;54:2506-14.
10. American Diabetes Association. Standards of medical care in diabetes - 2011. Diabetes Care 2011;34(suppl 1):S11-61.
11. Mingrone G, Castagneto-Gissey L. Mechanisms of early improvement/ resolution of type 2 diabetes after bariatric surgery. Diabetes Metab 2009;35:518-23.
12. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009;122:248-56.
13. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(suppl 1):S62-9.
14. Bruno G, De Micheli A, Frontoni S, Monge L, on behalf of SID-AMD Working Group on the Standards of Care for Diabetes Highlights from. Italian standards of care for diabetes mellitus 2009-2010. Nutr Metab Cardiovasc Dis 2011;21:302-14.
15. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total cholesterol in serum. Clin Chem 1974;20:470-5.
16. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973;19:476-82.
17. Racette SB, Weiss EP, Villareal DT, Arif H, Steger-May K, Schechtman KB, Fontana L, Klein S, Holloszy JO, The Washington University School of Medicine CALERIE Group. One year of caloric restriction in humans: feasibility and effects on body composition and abdominal adipose tissue. J Gerontol A Biol Sci Med Sci 2006;61:943-50. (Pubitemid 44413933)
18. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237(suppl 3):E214-23. (Pubitemid 9249478)
19. Copeland KC, Kenney F, Nair K. Heated dorsal hand vein sampling for metabolic studies: a reappraisal. Am J Physiol 1992;263:E1010-4.
20. Schmidt FH. [Enzymatic determination of glucose and fructose simultaneously.] Klin Wochenschr 1961;39:1244-7 (in German) .
21. Pfützner A, Löbig M, Fortunato A, Forst T. Evaluation of a new fully automated one-step C-Peptide Chemiluminescence Assay (LIAISON C-Peptid). Clin Lab 2003;49:227-32. (Pubitemid 36722835)
22. Sapin R. Review: insulin assays: previously known and new analytical features. Clin Lab 2003;49(suppl 3-4):S113-21.
23. Torelli JA, Eklund P, Levy E. Enhanced high-performance liquid chromatographic resolution of hemoglobin A1c at low temperatures. J Chromatogr 1982;233:334-7. (Pubitemid 13151678)
24. Briatore L, Salani B, Andraghetti G, Danovaro C, Sferrazzo E, Scopinaro N, Adami GF, Maggi D, Cordera R. Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion. Obesity (Silver Spring) 2008;16:77-81. (Pubitemid 351271953)
25. Mari A, Ahrén B, Pacini G. Assessment of insulin secretion in relation to insulin resistance. Curr Opin Clin Nutr Metab Care 2005;8:529-33. (Pubitemid 41192329)
26. Cobelli C, Toffolo GM, Dalla Man C, Campioni M, Denti P, Caumo A, Butler P, Rizza R. Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab 2007; 293:E1-15.
27. Cali' AM, Bonadonna RC, Trombetta M, Weiss R, Caprio S. Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents. J Clin Endocrinol Metab 2008;93:1767-73.
28. Giaccari A, Sorice G, Muscogiuri G. Glucose toxicity: the leading actor in the pathogenesis and clinical history of type 2 diabetes - mechanisms and potentials for treatment. Nutr Metab Cardiovasc Dis 2009;19: 365-77.
29. Camastra S, Gastaldelli A, Mari A, Bonuccelli S, Scartabelli G, Frascerra S, Baldi S, Nannipieri M, Rebelos E, Anselmino M, et al. Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia 2011;54: 2093-102.
30. Isbell JM, Tamboli RA, Hansen EN, Saliba J, Dunn JP, Phillips SE, Marks-Shulman PA, Abumrad NN. The importance of caloric restriction in the early improvements in insulin sensitivity after roux-en-Y gastric bypass surgery. Diabetes Care 2010;33:1438-42.
31. Dunn JP, Abumrad NN, Breitman I, Marks-Shulman PA, Flynn CR, Jabbour K, Feurer ID, Tamboli RA. Hepatic and peripheral insulin sensitivity and diabetes remission at 1 month after roux-en-Y gastric bypass surgery in patients randomized to omentectomy. Diabetes Care 2011 (Epub ahead of print 31 October 2011).